Many reports have identified NUF2 as an oncogene in various cancers, including clear cell renal cell carcinoma (Lin et al., 2022), melanoma (Wang et al., 2022), and breast cancer (Lv et al., 2020). The gene discussed is NUF2; the disease is cancer.